Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Lung Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 60 articles:
HTML format
Text format



Single Articles


    December 2011
  1. HUANG B , Liu B, Yang L, Li Y, et al
    Functional genetic variants of c-Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern chinese.
    Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27407.
    PubMed     Text format     Related articles    Abstract available



  2. XIAO J , Wang Y, Peng J, Guo L, et al
    A synthetic compound, 1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one (B63), induces apoptosis and activates endoplasmic reticulum stress in non-small cell lung cancer cells.
    Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27406.
    PubMed     Text format     Related articles    Abstract available



  3. CHUNG FT , Lee KY, Wang CW, Heh CC, et al
    Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Int J Cancer. 2011 Dec 15. doi: 10.1002/ijc.27403.
    PubMed     Text format     Related articles    Abstract available



  4. GAO G , Ren S, Li A, Xu J, et al
    Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: a meta-analysis from 6 phase III randomized controlled trials.
    Int J Cancer. 2011 Dec 13. doi: 10.1002/ijc.27396.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  5. OHUE Y , Eikawa S, Okazaki N, Mizote Y, et al
    Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
    Int J Cancer. 2011 Nov 22. doi: 10.1002/ijc.27359.
    PubMed     Text format     Related articles    Abstract available



  6. YAN L , Demars LC
    Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice.
    Int J Cancer. 2011 Nov 18. doi: 10.1002/ijc.27355.
    PubMed     Text format     Related articles    Abstract available



  7. SHIBA-ISHII A , Kano J, Morishita Y, Sato Y, et al
    High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma.
    Int J Cancer. 2011;129:2445-53.
    PubMed     Text format     Related articles    Abstract available



  8. PESCH B , Kendzia B, Gustavsson P, Jockel KH, et al
    Cigarette smoking and lung cancer - relative risk estimates for the major histological types from a pooled analysis of case-control studies.
    Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27339.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  9. KIM KM , Yu TK, Chu HH, Park HS, et al
    Expression of ER stress and autophagy-related molecules in human non-small cell lung cancer and premalignant lesions.
    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26463.
    PubMed     Text format     Related articles    Abstract available



  10. DOWLING P , Clarke C, Hennessy K, Torralbo-Lopez B, et al
    Analysis of acute phase proteins, AHSG, C3, CLI, HP and SAA reveals distinctive expression patterns associated with breast, colorectal and lung cancer.
    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26462.
    PubMed     Text format     Related articles    Abstract available



  11. WINDHORST S , Kalinina T, Schmid K, Blechner C, et al
    Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells.
    Int J Cancer. 2011;129:1300-9.
    PubMed     Text format     Related articles    Abstract available



  12. THOMAS-SCHOEMANN A , Lemare F, Mongaret C, Bermudez E, et al
    Bystander effect of vinorelbine alters antitumor immune response.
    Int J Cancer. 2011;129:1511-8.
    PubMed     Text format     Related articles    Abstract available



  13. MIR SU , Ahmed IS, Arnold S, Craven RJ, et al
    Elevated Pgrmc1 (progesterone receptor membrane component 1)/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
    Int J Cancer. 2011 Sep 14. doi: 10.1002/ijc.26432.
    PubMed     Text format     Related articles    Abstract available



  14. SCHULTZ-THATER E , Piscuoglio S, Iezzi G, Le Magnen C, et al
    MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
    Int J Cancer. 2011;129:1137-48.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  15. ZHANG YQ , Bianco A, Malkinson AM, Leoni VP, et al
    BARD1: An independent predictor of survival in non-small cell lung cancer.
    Int J Cancer. 2011 Aug 3. doi: 10.1002/ijc.26346.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  16. NIU C , Liang C, Guo J, Cheng L, et al
    Downregulation and growth inhibitory role of FHL1 in lung cancer.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26259.
    PubMed     Text format     Related articles    Abstract available



  17. WATANABE K , Emoto N, Hamano E, Sunohara M, et al
    Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26254.
    PubMed     Text format     Related articles    Abstract available



  18. KUMARSWAMY R , Mudduluru G, Ceppi P, Muppala S, et al
    MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting snai1 and is downregulated in non-small cell lung cancer.
    Int J Cancer. 2011 Jun 1. doi: 10.1002/ijc.26218.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  19. CEPPI P , Rapa I, Lo Iacono M, Righi L, et al
    Expression and pharmacological inhibition of thymidilate synthase and Src kinase in non-small cell lung cancer.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26188.
    PubMed     Text format     Related articles    Abstract available



  20. KHAN N , Afaq F, Khusro FH, Adhami VM, et al
    Dual inhibition of PI3K/AKT and mTOR signaling in human non-small cell lung cancer cells by a dietary flavonoid fisetin.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26178.
    PubMed     Text format     Related articles    Abstract available



  21. CHEN X , Hu Z, Wang W, Ba Y, et al
    Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non-invasive biomarkers for non-small cell lung cancer diagnosis.
    Int J Cancer. 2011 May 9. doi: 10.1002/ijc.26177.
    PubMed     Text format     Related articles    Abstract available



  22. SUNAGA N , Imai H, Shimizu K, Shames DS, et al
    Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26164.
    PubMed     Text format     Related articles   



  23. HEEGAARD NH , Schetter AJ, Welsh JA, Yoneda M, et al
    Circulating microRNA expression profiles in early stage non-small cell lung cancer.
    Int J Cancer. 2011 May 4. doi: 10.1002/ijc.26153.
    PubMed     Text format     Related articles   



    April 2011
  24. AOKAGE K , Ishii G, Ohtaki Y, Yamaguchi Y, et al
    Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation.
    Int J Cancer. 2011;128:1585-95.
    PubMed     Text format     Related articles    Abstract available



  25. ILIE MI , Hofman V, Ortholan C, Ammadi RE, et al
    Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis.
    Int J Cancer. 2011;128:1614-23.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  26. DAI J , Hu Z, Dong J, Xu L, et al
    Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese.
    Int J Cancer. 2011 Mar 15. doi: 10.1002/ijc.26067.
    PubMed     Text format     Related articles    Abstract available



  27. LIU WM , Gravett AM, Dalgleish AG
    The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.
    Int J Cancer. 2011;128:1471-80.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  28. TANAKA S , Hattori N, Ishikawa N, Shoda H, et al
    Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected non-small cell lung cancer.
    Int J Cancer. 2011 Feb 23. doi: 10.1002/ijc.26007.
    PubMed     Text format     Related articles   



  29. BIRAN A , Brownstein M, Haklai R, Kloog Y, et al
    Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: a new drug combination for cancer therapy.
    Int J Cancer. 2011;128:691-701.
    PubMed     Text format     Related articles    Abstract available



  30. YOSHIMATSU M , Toyokawa G, Hayami S, Unoki M, et al
    Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
    Int J Cancer. 2011;128:562-73.
    PubMed     Text format     Related articles    Abstract available



  31. ATCHISON EA , Gridley G, Carreon JD, Leitzmann MF, et al
    Risk of cancer in a large cohort of U.S. veterans with diabetes.
    Int J Cancer. 2011;128:635-43.
    PubMed     Text format     Related articles    Abstract available



  32. FRIEDMAN GD , Udaltsova N, Habel LA
    Norepinephrine antagonists and cancer risk.
    Int J Cancer. 2011;128:737-8.
    PubMed     Text format     Related articles   



  33. LEONE A , Graziano P, Gasbarra R, Paone G, et al
    Identification of EGFR mutations in lung sarcomatoid carcinoma.
    Int J Cancer. 2011;128:732-5.
    PubMed     Text format     Related articles   



    January 2011
  34. ARORA S , Ranade AR, Tran NL, Nasser S, et al
    MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25939.
    PubMed     Text format     Related articles    Abstract available



  35. YE XQ , Li Q, Wang GH, Sun FF, et al
    Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells.
    Int J Cancer. 2011 Jan 20. doi: 10.1002/ijc.25944.
    PubMed     Text format     Related articles   



  36. GAFFAL E , Landsberg J, Bald T, Sporleder A, et al
    Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



  37. ZHANG Q , McCorkle JR, Novak M, Yang M, et al
    Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
    Int J Cancer. 2011;128:40-50.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  38. YU L , Todd NW, Xing L, Xie Y, et al
    Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
    Int J Cancer. 2010;127:2870-8.
    PubMed     Text format     Related articles    Abstract available



  39. GEE GV , Koestler DC, Christensen BC, Sugarbaker DJ, et al
    Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
    Int J Cancer. 2010;127:2859-69.
    PubMed     Text format     Related articles    Abstract available



  40. FOY M , Spitz MR, Kimmel M, Gorlova OY, et al
    A smoking-based carcinogenesis model for lung cancer risk prediction.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  41. TANAKA H , Kimura T, Kudoh S, Mitsuoka S, et al
    Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  42. HOFMAN V , Ilie MI, Long E, Selva E, et al
    Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small cell lung carcinoma: Comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  43. STOCKWIN LH , Yu SX, Borgel S, Hancock C, et al
    Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
    Int J Cancer. 2010;127:2510-9.
    PubMed     Text format     Related articles    Abstract available



  44. ZHU W , Shan X, Wang T, Shu Y, et al
    miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
    Int J Cancer. 2010;127:2520-9.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  45. BECHER H , Winkler V
    Lung cancer mortality in Sub-Saharan Africa.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles   



  46. WU R , Abramson AL, Symons MH, Steinberg BM, et al
    Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression.
    Int J Cancer. 2010;127:2230-7.
    PubMed     Text format     Related articles    Abstract available



  47. AN Z , Dobra K, Lock JG, Stromblad S, et al
    Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration.
    Int J Cancer. 2010;127:1999-2008.
    PubMed     Text format     Related articles    Abstract available



  48. OH SS , Chang SC, Cai L, Cordon-Cardo C, et al
    Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.
    Int J Cancer. 2010;127:2169-82.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  49. KURODA H , Mochizuki S, Shimoda M, Chijiiwa M, et al
    ADAM28 is a serological and histochemical marker for non-small-cell lung cancers.
    Int J Cancer. 2010;127:1844-56.
    PubMed     Text format     Related articles    Abstract available



  50. ROFSTAD EK , Gaustad JV, Egeland TA, Mathiesen B, et al
    Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination.
    Int J Cancer. 2010;127:1535-46.
    PubMed     Text format     Related articles    Abstract available



  51. FARSACI B , Sabzevari H, Higgins JP, Di Bari MG, et al
    Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine.
    Int J Cancer. 2010;127:1603-13.
    PubMed     Text format     Related articles    Abstract available



  52. CHAOUACHI K , Sajid KM
    Cancer risks of hookah (shisha, narghile) tobacco use require further independent sound studies.
    Int J Cancer. 2010;127:1737-9.
    PubMed     Text format     Related articles   



    September 2010
  53. SANCHEZ-PALENCIA A , Gomez-Morales M, Gomez-Capilla JA, Pedraza V, et al
    Gene expression profiling reveals novel biomarkers in non-small cell lung cancer.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  54. HUANG X , Huang G, Song H, Chen L, et al
    Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  55. HE LR , Zhao HY, Li BK, Liu YH, et al
    Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small-cell lung cancer patients.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  56. PATEL K , Farlow EC, Kim AW, Lee BS, et al
    Enhancement of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  57. SORRENTINO R , Morello S, Grazia Giordano M, Arra C, et al
    CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  58. COLONNA M , Bossard N, Remontet L, Grosclaude P, et al
    Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers.
    Int J Cancer. 2010;127:924-31.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  59. SHANMUGAM R , Kusumanchi P, Appaiah H, Cheng L, et al
    A water soluble parthenolide analogue suppresses in vivo tumor growth of two tobacco associated cancers, lung and bladder cancer, by targeting NF-kappaB and generating reactive oxygen species.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  60. WANG CI , Wang CL, Wang CW, Chen CD, et al
    Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: